MX2018008803A - Pirimidinas sustituidas con arilo para su uso en la infeccion por virus influenza. - Google Patents
Pirimidinas sustituidas con arilo para su uso en la infeccion por virus influenza.Info
- Publication number
- MX2018008803A MX2018008803A MX2018008803A MX2018008803A MX2018008803A MX 2018008803 A MX2018008803 A MX 2018008803A MX 2018008803 A MX2018008803 A MX 2018008803A MX 2018008803 A MX2018008803 A MX 2018008803A MX 2018008803 A MX2018008803 A MX 2018008803A
- Authority
- MX
- Mexico
- Prior art keywords
- influenza virus
- virus infection
- aryl substituted
- substituted pyrimidines
- pyrimidines
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La invención se refiere a compuestos que tienen la estructura de fórmula (I) que se pueden utilizar para el tratamiento de infecciones de la gripe o contra estas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16152095 | 2016-01-20 | ||
| PCT/EP2017/051105 WO2017125506A1 (en) | 2016-01-20 | 2017-01-19 | Aryl substituted pyrimidines for use in influenza virus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018008803A true MX2018008803A (es) | 2018-11-09 |
| MX381314B MX381314B (es) | 2025-03-12 |
Family
ID=55345663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018008803A MX381314B (es) | 2016-01-20 | 2017-01-19 | Pirimidinas sustituidas con arilo para su uso en la infeccion por virus influenza |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10611755B2 (es) |
| EP (1) | EP3405466B1 (es) |
| JP (1) | JP6989509B2 (es) |
| KR (1) | KR20180100375A (es) |
| CN (1) | CN108473477B (es) |
| AU (1) | AU2017209925B2 (es) |
| BR (1) | BR112018014794A2 (es) |
| CA (1) | CA3010327A1 (es) |
| CL (1) | CL2018001960A1 (es) |
| CO (1) | CO2018007669A2 (es) |
| DK (1) | DK3405466T3 (es) |
| EA (1) | EA201891666A1 (es) |
| EC (1) | ECSP18061667A (es) |
| ES (1) | ES2850575T3 (es) |
| HR (1) | HRP20202051T1 (es) |
| HU (1) | HUE053078T2 (es) |
| LT (1) | LT3405466T (es) |
| MX (1) | MX381314B (es) |
| SI (1) | SI3405466T1 (es) |
| WO (1) | WO2017125506A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102050712B1 (ko) | 2009-06-17 | 2019-12-02 | 버텍스 파마슈티칼스 인코포레이티드 | 인플루엔자 바이러스 복제의 억제제 |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| MA42422A (fr) | 2015-05-13 | 2018-05-23 | Vertex Pharma | Inhibiteurs de la réplication des virus de la grippe |
| KR20180087290A (ko) | 2015-11-27 | 2018-08-01 | 얀센 사이언시즈 아일랜드 유씨 | 인플루엔자 바이러스 감염에서 사용하기 위한 복소환식 인돌 |
| MX381314B (es) * | 2016-01-20 | 2025-03-12 | Janssen Sciences Ireland Uc | Pirimidinas sustituidas con arilo para su uso en la infeccion por virus influenza |
| WO2018033082A1 (en) * | 2016-08-16 | 2018-02-22 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication, application methods and uses thereof |
| CN109641868B (zh) | 2016-08-30 | 2021-12-03 | 广东东阳光药业有限公司 | 流感病毒复制抑制剂及其使用方法和用途 |
| EP3555095B1 (en) | 2016-12-15 | 2023-04-12 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication and uses thereof |
| WO2018127096A1 (en) | 2017-01-05 | 2018-07-12 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication and uses thereof |
| CN110446711B (zh) | 2017-03-02 | 2022-02-15 | 广东东阳光药业有限公司 | 流感病毒复制抑制剂及其用途 |
| MA54261B1 (fr) * | 2019-01-18 | 2025-03-28 | Astrazeneca Ab | Inhibiteurs de pcsk9 et leurs procédés d'utilisation |
| EP3911640A4 (en) | 2019-01-18 | 2022-10-26 | Astrazeneca AB | PCSK9 INHIBITORS AND METHODS OF USE THEREOF |
| CN119504738A (zh) * | 2023-08-25 | 2025-02-25 | 武汉人福创新药物研发中心有限公司 | 作为mrgprx2拮抗剂的化合物及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1931674B1 (en) | 2005-09-30 | 2012-12-12 | Vertex Pharmaceuticals Incorporated | Deazapurines useful as inhibitors of janus kinases |
| US8937080B2 (en) * | 2007-02-08 | 2015-01-20 | Medivir Ab | Pyrimidine substituted macrocyclic HCV inhibitors |
| KR102050712B1 (ko) | 2009-06-17 | 2019-12-02 | 버텍스 파마슈티칼스 인코포레이티드 | 인플루엔자 바이러스 복제의 억제제 |
| US9326987B2 (en) | 2010-09-08 | 2016-05-03 | Glaxo Group Limited | Indazole derivatives for use in the treatment of influenza virus infection |
| JP2013545818A (ja) * | 2010-12-16 | 2013-12-26 | バーテックス ファーマシューティカルズ インコーポレイテッド | インフルエンザウイルス複製阻害物質 |
| WO2012083117A1 (en) | 2010-12-16 | 2012-06-21 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| JP6046694B2 (ja) * | 2011-04-08 | 2016-12-21 | ヤンセン・サイエンシズ・アイルランド・ユーシー | ウイルス感染治療用のピリミジン誘導体 |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| WO2013184985A1 (en) | 2012-06-08 | 2013-12-12 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| LT2909195T (lt) * | 2012-10-16 | 2017-09-25 | Janssen Sciences Ireland Uc | Antivirusiniai rsv junginiai |
| EP2958900B1 (en) * | 2013-02-21 | 2019-04-10 | Janssen Sciences Ireland Unlimited Company | 2-aminopyrimidine derivatives for the treatment of viral infections |
| KR20180087290A (ko) | 2015-11-27 | 2018-08-01 | 얀센 사이언시즈 아일랜드 유씨 | 인플루엔자 바이러스 감염에서 사용하기 위한 복소환식 인돌 |
| MX381314B (es) * | 2016-01-20 | 2025-03-12 | Janssen Sciences Ireland Uc | Pirimidinas sustituidas con arilo para su uso en la infeccion por virus influenza |
-
2017
- 2017-01-19 MX MX2018008803A patent/MX381314B/es unknown
- 2017-01-19 WO PCT/EP2017/051105 patent/WO2017125506A1/en not_active Ceased
- 2017-01-19 US US16/071,649 patent/US10611755B2/en not_active Expired - Fee Related
- 2017-01-19 EA EA201891666A patent/EA201891666A1/ru unknown
- 2017-01-19 KR KR1020187022179A patent/KR20180100375A/ko not_active Ceased
- 2017-01-19 ES ES17700580T patent/ES2850575T3/es active Active
- 2017-01-19 HU HUE17700580A patent/HUE053078T2/hu unknown
- 2017-01-19 LT LTEP17700580.8T patent/LT3405466T/lt unknown
- 2017-01-19 SI SI201730580T patent/SI3405466T1/sl unknown
- 2017-01-19 JP JP2018537626A patent/JP6989509B2/ja not_active Expired - Fee Related
- 2017-01-19 EP EP17700580.8A patent/EP3405466B1/en active Active
- 2017-01-19 AU AU2017209925A patent/AU2017209925B2/en not_active Ceased
- 2017-01-19 BR BR112018014794A patent/BR112018014794A2/pt not_active IP Right Cessation
- 2017-01-19 CN CN201780007200.1A patent/CN108473477B/zh not_active Expired - Fee Related
- 2017-01-19 HR HRP20202051TT patent/HRP20202051T1/hr unknown
- 2017-01-19 CA CA3010327A patent/CA3010327A1/en active Pending
- 2017-01-19 DK DK17700580.8T patent/DK3405466T3/da active
-
2018
- 2018-07-19 CL CL2018001960A patent/CL2018001960A1/es unknown
- 2018-07-24 CO CONC2018/0007669A patent/CO2018007669A2/es unknown
- 2018-08-15 EC ECSENADI201861667A patent/ECSP18061667A/es unknown
-
2020
- 2020-04-03 US US16/840,279 patent/US11117887B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN108473477A (zh) | 2018-08-31 |
| EP3405466A1 (en) | 2018-11-28 |
| US20200231577A1 (en) | 2020-07-23 |
| ES2850575T3 (es) | 2021-08-30 |
| ECSP18061667A (es) | 2018-10-31 |
| US20190047989A1 (en) | 2019-02-14 |
| HRP20202051T1 (hr) | 2021-02-19 |
| US11117887B2 (en) | 2021-09-14 |
| EA201891666A1 (ru) | 2019-01-31 |
| AU2017209925B2 (en) | 2021-04-08 |
| CL2018001960A1 (es) | 2018-08-31 |
| BR112018014794A2 (pt) | 2018-12-11 |
| CN108473477B (zh) | 2021-10-22 |
| DK3405466T3 (da) | 2021-02-01 |
| US10611755B2 (en) | 2020-04-07 |
| CA3010327A1 (en) | 2017-07-27 |
| MX381314B (es) | 2025-03-12 |
| SI3405466T1 (sl) | 2021-02-26 |
| EP3405466B1 (en) | 2020-11-18 |
| HUE053078T2 (hu) | 2021-06-28 |
| JP2019507119A (ja) | 2019-03-14 |
| WO2017125506A1 (en) | 2017-07-27 |
| JP6989509B2 (ja) | 2022-01-05 |
| KR20180100375A (ko) | 2018-09-10 |
| AU2017209925A1 (en) | 2018-07-12 |
| LT3405466T (lt) | 2021-01-25 |
| CO2018007669A2 (es) | 2018-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018007669A2 (es) | Pirimidinas sustituidas con arilo para su uso en la infección por virus influenza | |
| MX2017001752A (es) | Indoles para su uso en la infección por el virus de la gripe. | |
| CL2017000533A1 (es) | Pirrolopirimidinas para uso en la infección por el virus de la gripe | |
| JOP20180123A1 (ar) | مركبات علاجية مفيدة للوقاية من أو علاج الإصابة بفيروس نقص المناعة البشرية | |
| MX2017008720A (es) | Derivados y metodos para tratamiento de las infecciones por hepatitis b. | |
| MX2016009337A (es) | Derivados de azepano y metodos para tratar infecciones por hepatitis b. | |
| EA201692316A1 (ru) | Производные холана для применения при лечении и/или профилактике fxr и tgr5/gpbar1-опосредованных заболеваний | |
| CL2016000493A1 (es) | Inhibidores de polimerasa hcv. | |
| CO7170160A2 (es) | Nuevas 6-aminoacido-heteroarildihidropirimidinas para el tratamiento y profilaxis de la infección del virus de la hepatitis b | |
| CR20150337A (es) | Derivados de pirimidinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral | |
| DOP2016000336A (es) | Derivados de isoindolina para uso en el tratamiento de una infeccion viral | |
| PL3504214T3 (pl) | Skondensowane trójpierścieniowe związki pirydazynonowe przydatne w leczeniu infekcji ortomyksowirusami | |
| EA201891644A1 (ru) | Антибактериальные соединения и их применение | |
| CL2020001147A1 (es) | Compuestos antibacterianos | |
| EA201891278A1 (ru) | Гетероциклические индолы для применения при инфекции, вызванной вирусом гриппа | |
| UY36221A (es) | Derivados de isoindolinona | |
| EA201891576A1 (ru) | Функционализированные пентановые кислоты для применения при инфекциях, вызванных вирусом гриппа | |
| BR112017008496A2 (pt) | compostos para uso em tratamento antelmíntico | |
| CL2017000178A1 (es) | Compuestos para usar en el tratamiento antihelmíntico | |
| UY36217A (es) | Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso. | |
| EA201690594A1 (ru) | Состав для лечения вич-инфекции на основе атазанавира и кобицистата | |
| CL2017002449A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
| CL2016001977A1 (es) | Composición que comprende igm derivada de plasma y su uso para el tratamiento o prevención de afecciones inmunitarias. | |
| CL2019002203A1 (es) | Nuevos compuestos heterocíclicos y sus usos en la prevención o el tratamiento de infecciones bacterianas. | |
| MX386783B (es) | Compuestos peptidomiméticos que neutralizan el virus influenza. |